INmune Bio (INMB)
Develops innate-immunity therapies for rare disease, Alzheimer’s disease and cancer.
$2.02
vs last close−0.15 (−6.71%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 15.66% | 4.35M shares | |
|---|---|---|---|
| 87 holders · as of Jun 30, 2026 | |||
| Insiders | 10.45% | 2.90M shares | |
| 3 holders · as of Jul 7, 2026 | |||
| Strategic holders | 5.24% | 1.45M shares | |
| 1 holder · as of Aug 14, 2025 | |||
| Other | 68.65% | 19.05M shares | |
| remainder | |||
27.75M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
87 holders · 4.35M shares · 24 new positions · 52 increased · 21 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 706.4K | 2.55% | +19.4K | Aug 13, 2026 |
| AQR Capital Management LLC | 662.2K | 2.39% | +391.9K | Aug 14, 2026 |
| BlackRock, Inc. | 311.6K | 1.12% | −882.5K | Aug 7, 2026 |
| Raymond James Financial Inc | 213.0K | 0.77% | +9.8K | Aug 14, 2026 |
| Geode Capital Management, LLC | 190.2K | 0.69% | −304.8K | Aug 12, 2026 |
| Goldman Sachs Group Inc | 185.2K | 0.67% | −46.3K | Aug 14, 2026 |
| Millennium Management LLC | 159.6K | 0.57% | +159.6Knew | Aug 14, 2026 |
| Susquehanna International Group, LLP | 158.5K | 0.57% | −35.9K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 5.20% | 1.45M | 13G | Aug 14, 2025 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.